At our Novashore division, we have perfected an agile, efficient, and seamless talent acquisition process designed to fulfill all your staffing and hiring needs. With NOVACOMP as your partner, you can expect nothing less than excellence in every aspect of your business journey.

In recent years, Novacomp has experienced exponential growth, consolidating itself as a recognized company in the Nearshoring-Onshore and Agile Software Development – working across diverse industries such as: Financial Services, Telecommunications, Healthcare, Logistics and Manufacturing. The company has also specialized in Data Analytics & A.I., Cloud & Infrastructure, RPA and Modern Workplace services.

WorkFusion specializes in AI-driven automation solutions, particularly for financial institutions. Their AI Digital Workers are designed to enhance productivity, regulatory compliance, and customer satisfaction by automating complex processes like anti-money laundering (AML), sanctions screening, and customer due diligence. These pre-trained AI models can be quickly integrated into existing workflows, offering significant improvements in efficiency and accuracy while reducing manual labor and operational costs. 

Fuse Analytics specializes in HR and ERP data archiving, ensuring secure, accessible, and compliant retention of legacy data. They provide a cloud-based solution compatible with major HCM and payroll applications, offering features like role-based access, end-to-end encryption, and advanced analytics. Their services help companies maintain data integrity during system migrations, enhancing productivity and compliance with regulations.

XWRAP customers have provided anecdotal evidence suggesting that XWRAP outperforms other skin substitutes currently available in the market. This superiority stems from its unique processing, dehydration, and sterilization methods. The proprietary processing of XWRAP has demonstrated superior handling and biodegradability characteristics. It exhibits a slower and more controlled breakdown, thereby offering prolonged and enhanced performance as a protective cover and wound barrier. The product undergoes natural dehydration without heat and a gentle sterilization process, which helps preserve its durability and extracellular matrix. In contrast, similar products not subjected to such sterilization tend to rapidly degrade, resulting in inferior performance compared to XWRAP. XWRAP has been selected for its exceptional performance attributes, expected to reduce product usage and enhance patient outcomes. Ongoing clinical studies on XWRAP are currently underway, with results anticipated for publication by the end of the year.